Orthofix officer proposes 450-share stock sale

Orthofix Medical Inc. (OFIX) is the issuer in a Form 144 filing by Patrick Fisher, an officer, covering a proposed resale of company common stock under Rule 144.

Rhea-AI Filing Summary

Orthofix Medical Inc. (OFIX) is the issuer in a Form 144 filing by Patrick Fisher, an officer, covering a proposed resale of company common stock under Rule 144. The notice contemplates the sale of 450 shares of Orthofix common stock through Morgan Stanley Smith Barney on NASDAQ.

The 450 shares relate to Restricted Stock Units acquired from the issuer on 08/15/2025. The filing also reports that during the past three months Patrick Fisher sold 1,295 shares of Orthofix common stock on 08/18/2026.

Key Figures

Shares to be sold: 450 shares Aggregate market value of shares to be sold: $4,225.50 Approximate date of sale: 09/01/2026 +3 more

6 metrics

Shares to be sold 450 shares Common stock proposed to be sold under Rule 144

Aggregate market value of shares to be sold $4,225.50 Estimated value for 450 Orthofix common shares

Approximate date of sale 09/01/2026 Planned timing for Rule 144 sale on NASDAQ

Date RSUs acquired 08/15/2025 Acquisition date of Restricted Stock Units underlying 450 shares

Shares sold in past 3 months 1,295 shares Common shares sold by Patrick Fisher on 08/18/2026

Proceeds from past 3‑month sale $13,066.55 Total received for 1,295 Orthofix common shares on 08/18/2026

Key Terms

Rule 144, Restricted Stock Units, Aggregate market value

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Units financial

"Restricted Stock Units | Issuer | | | 450 | 08/15/2025"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Aggregate market value financial

"Common | ... | 450 | 4225.50 | 40732608 | 09/01/2026"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

What does the Form 144 filing disclose for Orthofix Medical Inc. (OFIX)?

It discloses that officer Patrick Fisher has notified of his intent under Rule 144 to potentially sell 450 shares of Orthofix Medical Inc. common stock through Morgan Stanley Smith Barney on NASDAQ, based on equity previously received from the issuer.

How many Orthofix (OFIX) shares are planned to be sold under this Form 144?

The notice covers a proposed sale of 450 shares of Orthofix Medical Inc. common stock, with an indicated aggregate market value of $4,225.50, to be sold through Morgan Stanley Smith Barney on NASDAQ.

When were the Orthofix (OFIX) shares in this Form 144 acquired?

The 450 shares covered by the Form 144 relate to Restricted Stock Units acquired from Orthofix Medical Inc. on 08/15/2025, as indicated in the Securities To Be Sold section.

What past Orthofix (OFIX) stock sales by Patrick Fisher are reported?

The filing reports that Patrick Fisher sold 1,295 shares of Orthofix common stock on 08/18/2026, for total proceeds of $13,066.55, during the three months preceding this notice.

Which broker is handling the proposed Orthofix (OFIX) share sale in this Form 144?

The proposed sale of 450 Orthofix common shares is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, as stated in the securities information.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/01/2026 - 04:42 PM Accepted by SEC EDGAR 09/01/2026 - 04:40 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001677842
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ORTHOFIX MEDICAL INC.
SEC File Number	000-19961
Address of Issuer	3451 Plano Parkway Lewisville TEXAS 75056
Phone	214-937-2000
Name of Person for Whose Account the Securities are To Be Sold	PATRICK FISHER
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	450	4225.50	40732608	09/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/15/2025	Restricted Stock Units	Issuer			450	08/15/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
PATRICK FISHER 3451 Plano Parkway Lewisville TX 75056	Common	08/18/2026	1295	13066.55

144: Remarks and Signature

Remarks
Date of Notice	09/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/29/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Patrick Fisher
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)